Prognostic significance of monosomal karyotype in myelodysplastic syndrome: a meta-analysis

References

• Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361(19):1872–1885. doi: 10.1056/NEJMra0902908
   PubMed Web of Science ®Google Scholar
• Nimer SD. Myelodysplastic syndromes. Blood. 2008;111(10):4841–4851. doi: 10.1182/blood-2007-08-078139
   PubMed Web of Science ®Google Scholar
• Malcovati L, Della Porta MG, Strupp C, et al. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based prognostic scoring system (WPSS). Haematologica. 2011;96(10):1433–1440. doi: 10.3324/haematol.2011.044602
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079–2088.
   PubMed Web of Science ®Google Scholar
• Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465. doi: 10.1182/blood-2012-03-420489
   PubMed Web of Science ®Google Scholar
• Breems DA, Val Putten WL, De Greef GE, et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol. 2008;26(29):4791–4797. doi: 10.1200/JCO.2008.16.0259
   PubMed Web of Science ®Google Scholar
• Medeiros BC, Othus M, Fang M, et al. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the southwest oncology group (SWOG) experience. Blood. 2010;116(13):2224–2228. doi: 10.1182/blood-2010-02-270330
   PubMed Web of Science ®Google Scholar
• Della Porta MG, Alessandrino EP, Bacigalupo A, et al. Predictive factors for the outcome of allogeneic transplantation inpatients with MDS stratified according to the revised IPSS-R. Blood. 2014;123(15):2333–2342. doi: 10.1182/blood-2013-12-542720
   PubMed Web of Science ®Google Scholar
• Xing R, Li C, Gale RP, et al. Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndrome. Am J Hematol. 2014;89(10):E163–E168. doi: 10.1002/ajh.23801
   PubMed Web of Science ®Google Scholar
• McQuilten ZK, Sundararajan V, Andrianopoulos N, et al. Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes. Cancer. 2015;121(17):2892–2899. doi: 10.1002/cncr.29396
   PubMed Web of Science ®Google Scholar
• Yahng SA, Jeon YW, Yoon JH, et al. Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome. Bone Marrow Transplant. 2017;52(4):522–531. doi: 10.1038/bmt.2016.295
   PubMed Web of Science ®Google Scholar
• Mo XD, Zhang XH, Xu LP, et al. Haploidentical hematopoietic stem cell transplantation for myelodysplastic syndrome. Biol Blood Marrow Transplant. 2017;23(12):2143–2150. doi: 10.1016/j.bbmt.2017.08.026
   PubMed Web of Science ®Google Scholar
• Schanz J, Tuchler H, Sole F, et al. Monosomal karyotype in MDS: explaining the poor prognosis? Leukemia. 2013;27(10):1988–1995. doi: 10.1038/leu.2013.187
   PubMed Web of Science ®Google Scholar
• Valcarcel D, Adema V, Sole F, et al. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome. J Clin Oncol. 2013;31(7):916–922. doi: 10.1200/JCO.2012.41.6073
   PubMed Web of Science ®Google Scholar
• Hwang KL, Soong MK, Shin HJ, et al. Monosomal and complex karyotypes as prognostic parameters in patients with international prognostic scoring system higher risk myelodysplastic syndrome treated with azacitidine. Blood Res. 2014;49(4):234–240. doi: 10.5045/br.2014.49.4.234
   PubMedGoogle Scholar
• Kelaidi C, Tzannou I, Baltadakis I, et al. Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes. Bone Marrow Transplant. 2014;49(8):1022–1028. doi: 10.1038/bmt.2014.87
   PubMed Web of Science ®Google Scholar
• Patnaik MM, Hanson CA, Hodnefield JM, et al. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia. 2011;25(2):266–270. doi: 10.1038/leu.2010.258
   PubMed Web of Science ®Google Scholar
• Itzykson R, Thepot S, Eclache V, et al. Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine. Luekemia. 2011;25(7):1207–1209. doi: 10.1038/leu.2011.63
   PubMed Web of Science ®Google Scholar
• Suh KJ, Cheong JW, Kim I, et al. Prognostic impact of IPSS-R and chromosomal translocations in 751 Korean patients with primary myelodysplastic syndrome. PloS one. 2016;11(11):e0166245. doi: 10.1371/journal.pone.0166245
   PubMed Web of Science ®Google Scholar
• Zhang T, Xu Y, Pan J, et al. Monosomal karyotype of chromosome 5/7 was an independent poor prognostic factor for Chinese myelodysplastic syndrome patients. Cancer Genet. 2016;209(9):423–429. doi: 10.1016/j.cancergen.2016.06.007
   PubMed Web of Science ®Google Scholar
• Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815–2834. doi: 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi: 10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101. doi: 10.2307/2533446
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Wudhikarn K, Van Rheeden R, Leopold C, et al. Outcome of allogeneic stem cell transplantation in myelodysplastic syndrome patients: prognostic implication of monosomal karyotype. Eur J Haematol. 2012;89(4):294–301. doi: 10.1111/j.1600-0609.2012.01830.x
   PubMed Web of Science ®Google Scholar
• Deeg HJ, Scott BL, Fang M, et al. Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS. Blood. 2012;120(7):1398–1408. doi: 10.1182/blood-2012-04-423046
   PubMed Web of Science ®Google Scholar
• Ustun C, Trottier BJ, Sachs Z, et al. Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome. Biol Blood Marrow Transplant. 2015;21(5):866–872. doi: 10.1016/j.bbmt.2015.01.017
   PubMed Web of Science ®Google Scholar
• Alsahlawi A, Alkhateeb H, Patnaik M, et al. Monosomal karyotype predicts adverse prognosis in patients diagnosed with chronic myelomonocytic leukemia: a single-institution experience. Clin Lymphoma Myeloma Leuk. 2015;15(2):e39–e41. doi: 10.1016/j.clml.2014.06.007
   PubMedGoogle Scholar
• Rucker FG, Schlenk RF, Bullinger L, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood. 2012;119(9):2114–2121. doi: 10.1182/blood-2011-08-375758
   PubMed Web of Science ®Google Scholar